<DOC>
	<DOCNO>NCT01945684</DOCNO>
	<brief_summary>Purpose : This study Randomized , Double Blind , Multi-center , Active Drug Controlled , Phase III Clinical Trial Compare Safety Efficacy DWP450 Versus Botox® Treatment Post Stroke Upper Limb ( wrist , finger , elbow , thumb ) Spasticity .</brief_summary>
	<brief_title>A Randomized , Double Blind , Multi-center , Active Drug Controlled , Phase III Clinical Trial Compare Safety Efficacy DWP450 Versus Botox® Treatment Post Stroke Upper Limb Spasticity</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>1 . Male female adult patient 2 . ≥ 6 week since last stroke 1.Patients diagnose neuromuscular disorder LamberEaton syndrome , myasthenia gravis , amyotrophic lateral sclerosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>